Alteplase biosimilar (Generium)

阿替普酶生物类似药 (Generium)

Report date: 2026/03/26 20:00:17

Base Information

Drug NameAlteplase biosimilar (Generium)
Drug Alias NameRevelizaReveliseGNR-004
ClassificationBiologics > Protein drugs > Enzyme > Recombinant enzymeBiologics > Protein drugs > Recombinant protein > Recombinant enzymeBiologics > Biosimilar
Mechanisms of ActionPlasminogen stimulants
TargetsPlasminogen
Therapy Area/IndicationsIschemic StrokeMyocardial InfarctionPulmonary Embolism
Global Approved IndicationsIschemic StrokeMyocardial InfarctionPulmonary Embolism
Approved Indications in ChinaN/A
Original Approved Country/TerritoryRussian Federation
Original Approved Date2018/11/01
Country/TerritoryRussian Federation
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsIschemic StrokeMyocardial InfarctionPulmonary Embolism
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A